Open Access
Open access
volume 28 issue 8 pages 3416

Identification of Novel Cyclooxygenase-1 Selective Inhibitors of Thiadiazole-Based Scaffold as Potent Anti-Inflammatory Agents with Safety Gastric and Cytotoxic Profile

Michelyne Haroun 1
Maria Fesatidou 2
Anthi Petrou 2
Christophe Tratrat 1
Panagiotis Zagaliotis 2, 3
Antonis Gavalas 2
Hafedh Kochkar 5, 6
P. Emeka 1
Nancy S. Younis 1
Dalia Ahmed Elmaghraby 7
Mervt M Almostafa 8
Muhammad Shahzad Chohan 9
Ioannis S Vizirianakis 10, 11
Aliki Papadimitriou Tsantarliotou 10
Publication typeJournal Article
Publication date2023-04-12
scimago Q1
wos Q2
SJR0.865
CiteScore8.6
Impact factor4.6
ISSN14203049
Organic Chemistry
Drug Discovery
Physical and Theoretical Chemistry
Pharmaceutical Science
Molecular Medicine
Analytical Chemistry
Chemistry (miscellaneous)
Abstract

Major obstacles faced by the use of nonsteroidal anti-inflammatory drugs (NSAID) are their gastrointestinal toxicity induced by non-selective inhibition of both cyclooxygenases (COX) 1 and 2 and their cardiotoxicity associated with a certain class of COX-2 selective inhibitors. Recent studies have demonstrated that selective COX-1 and COX-2 inhibition generates compounds with no gastric damage. The aim of the current study is to develop novel anti-inflammatory agents with a better gastric profile. In our previous paper, we investigated the anti-inflammatory activity of 4-methylthiazole-based thiazolidinones. Thus, based on these observations, herein we report the evaluation of anti-inflammatory activity, drug action, ulcerogenicity and cytotoxicity of a series of 5-adamantylthiadiazole-based thiazolidinone derivatives. The in vivo anti-inflammatory activity revealed that the compounds possessed moderate to excellent anti-inflammatory activity. Four compounds 3, 4, 10 and 11 showed highest potency (62.0, 66.7, 55.8 and 60.0%, respectively), which was higher than the control drug indomethacin (47.0%). To determine their possible mode of action, the enzymatic assay was conducted against COX-1, COX-2 and LOX. The biological results demonstrated that these compounds are effective COX-1 inhibitors. Thus, the IC50 values of the three most active compounds 3, 4 and 14 as COX-1 inhibitors were 1.08, 1.12 and 9.62 μΜ, respectively, compared to ibuprofen (12.7 μΜ) and naproxen (40.10 μΜ) used as control drugs. Moreover, the ulcerogenic effect of the best compounds 3, 4 and 14 were evaluated and revealed that no gastric damage was observed. Furthermore, compounds were found to be nontoxic. A molecular modeling study provided molecular insight to rationalize the COX selectivity. In summary, we discovered a novel class of selective COX-1 inhibitors that could be effectively used as potential anti-inflammatory agents.

Found 
Found 

Top-30

Journals

1
Assay and Drug Development Technologies
1 publication, 12.5%
Bioorganic and Medicinal Chemistry
1 publication, 12.5%
Archiv der Pharmazie
1 publication, 12.5%
Oriental Journal Of Chemistry
1 publication, 12.5%
ChemMedChem
1 publication, 12.5%
Therapeutic Advances in Drug Safety
1 publication, 12.5%
Chemistry and Biodiversity
1 publication, 12.5%
1

Publishers

1
2
3
Wiley
3 publications, 37.5%
Royal Society of Chemistry (RSC)
1 publication, 12.5%
Mary Ann Liebert
1 publication, 12.5%
Elsevier
1 publication, 12.5%
Oriental Scientific Publishing Company
1 publication, 12.5%
SAGE
1 publication, 12.5%
1
2
3
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
8
Share
Cite this
GOST |
Cite this
GOST Copy
Haroun M. et al. Identification of Novel Cyclooxygenase-1 Selective Inhibitors of Thiadiazole-Based Scaffold as Potent Anti-Inflammatory Agents with Safety Gastric and Cytotoxic Profile // Molecules. 2023. Vol. 28. No. 8. p. 3416.
GOST all authors (up to 50) Copy
Haroun M., Fesatidou M., Petrou A., Tratrat C., Zagaliotis P., Gavalas A., Venugopala K. N., Kochkar H., Emeka P., Younis N., Elmaghraby D. A., Almostafa M. M., Chohan M. S., Vizirianakis I. S., Papadimitriou Tsantarliotou A., Geronikaki A. Identification of Novel Cyclooxygenase-1 Selective Inhibitors of Thiadiazole-Based Scaffold as Potent Anti-Inflammatory Agents with Safety Gastric and Cytotoxic Profile // Molecules. 2023. Vol. 28. No. 8. p. 3416.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.3390/molecules28083416
UR - https://doi.org/10.3390/molecules28083416
TI - Identification of Novel Cyclooxygenase-1 Selective Inhibitors of Thiadiazole-Based Scaffold as Potent Anti-Inflammatory Agents with Safety Gastric and Cytotoxic Profile
T2 - Molecules
AU - Haroun, Michelyne
AU - Fesatidou, Maria
AU - Petrou, Anthi
AU - Tratrat, Christophe
AU - Zagaliotis, Panagiotis
AU - Gavalas, Antonis
AU - Venugopala, Katharigatta N.
AU - Kochkar, Hafedh
AU - Emeka, P.
AU - Younis, Nancy S.
AU - Elmaghraby, Dalia Ahmed
AU - Almostafa, Mervt M
AU - Chohan, Muhammad Shahzad
AU - Vizirianakis, Ioannis S
AU - Papadimitriou Tsantarliotou, Aliki
AU - Geronikaki, Athina
PY - 2023
DA - 2023/04/12
PB - MDPI
SP - 3416
IS - 8
VL - 28
PMID - 37110650
SN - 1420-3049
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2023_Haroun,
author = {Michelyne Haroun and Maria Fesatidou and Anthi Petrou and Christophe Tratrat and Panagiotis Zagaliotis and Antonis Gavalas and Katharigatta N. Venugopala and Hafedh Kochkar and P. Emeka and Nancy S. Younis and Dalia Ahmed Elmaghraby and Mervt M Almostafa and Muhammad Shahzad Chohan and Ioannis S Vizirianakis and Aliki Papadimitriou Tsantarliotou and Athina Geronikaki},
title = {Identification of Novel Cyclooxygenase-1 Selective Inhibitors of Thiadiazole-Based Scaffold as Potent Anti-Inflammatory Agents with Safety Gastric and Cytotoxic Profile},
journal = {Molecules},
year = {2023},
volume = {28},
publisher = {MDPI},
month = {apr},
url = {https://doi.org/10.3390/molecules28083416},
number = {8},
pages = {3416},
doi = {10.3390/molecules28083416}
}
MLA
Cite this
MLA Copy
Haroun, Michelyne, et al. “Identification of Novel Cyclooxygenase-1 Selective Inhibitors of Thiadiazole-Based Scaffold as Potent Anti-Inflammatory Agents with Safety Gastric and Cytotoxic Profile.” Molecules, vol. 28, no. 8, Apr. 2023, p. 3416. https://doi.org/10.3390/molecules28083416.